Methenamine Hippurate (Leading Pharma, LLC)


Welcome to the PulseAid listing for the Methenamine Hippurate drug offered from Leading Pharma, LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Leading Pharma, LLC
NON-PROPRIETARY NAME: Methenamine Hippurate
SUBSTANCE NAME: METHENAMINE HIPPURATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2016-06-03
END MARKETING DATE: 0000-00-00


Methenamine Hippurate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMethenamine Hippurate from Leading Pharma, LLC
LABELER NAME: Leading Pharma, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/1)
START MARKETING DATE: 2016-06-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69315-210_54702112-6d67-4ceb-89c8-db1e38d5bce0
PRODUCT NDC: 69315-210
APPLICATION NUMBER: NDA017681

Other METHENAMINE HIPPURATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Methenamine Hippurate
Aurobindo Pharma LimitedMethenamine Hippurate
Carilion Materials ManagementMethenamine Hippurate
CorePharma, LLCMethenamine Hippurate
County Line Pharmaceuticals, LLCMethenamine Hippurate
Leading Pharma, LLCMethenamine Hippurate
Sanofi-Aventis U.S. LLCHiprex
Validus Pharmaceuticals LLCHIPREX
Winthrop U.S.Methenamine Hippurate